quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:45:00·43d
PRRelease
BioNexus Gene Lab Corp logo

BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform

BGLC· BioNexus Gene Lab Corp
Health Care
Original source

Companies

  • BGLC
    BioNexus Gene Lab Corp
    Health Care

Related

  • SEC9d
    SEC Form 10-K filed by BioNexus Gene Lab Corp
  • SEC23d
    SEC Form NT 10-K filed by BioNexus Gene Lab Corp
  • SEC37d
    BioNexus Gene Lab Corp filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
  • SEC59d
    BioNexus Gene Lab Corp filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR59d
    BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman
  • SEC79d
    BioNexus Gene Lab Corp filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR85d
    BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN's Multi-Billion Dollar Market
  • SEC114d
    BioNexus Gene Lab Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022